Key Financial Data Of Group

JCR Pharmaceuticals Co.,Ltd. - Filing #7326592

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of group
Business results of group
Net sales
42,871,000,000 JPY
42,871,000,000 JPY
34,343,000,000 JPY
34,343,000,000 JPY
51,081,000,000 JPY
51,082,000,000 JPY
30,085,000,000 JPY
30,085,000,000 JPY
24,725,000,000 JPY
24,781,000,000 JPY
Ordinary profit (loss)
8,048,000,000 JPY
7,264,000,000 JPY
5,284,000,000 JPY
5,418,000,000 JPY
20,425,000,000 JPY
20,512,000,000 JPY
8,594,000,000 JPY
8,488,000,000 JPY
3,342,000,000 JPY
3,293,000,000 JPY
Profit (loss) attributable to owners of parent
5,507,000,000 JPY
3,772,000,000 JPY
14,507,000,000 JPY
6,892,000,000 JPY
2,678,000,000 JPY
Comprehensive income
6,475,000,000 JPY
3,881,000,000 JPY
14,514,000,000 JPY
6,841,000,000 JPY
2,504,000,000 JPY
Net assets
56,475,000,000 JPY
56,141,000,000 JPY
52,006,000,000 JPY
52,413,000,000 JPY
51,089,000,000 JPY
50,939,000,000 JPY
38,557,000,000 JPY
38,546,000,000 JPY
32,579,000,000 JPY
32,278,000,000 JPY
Total assets
102,226,000,000 JPY
102,102,000,000 JPY
94,551,000,000 JPY
94,937,000,000 JPY
97,134,000,000 JPY
97,033,000,000 JPY
73,784,000,000 JPY
73,727,000,000 JPY
47,775,000,000 JPY
47,440,000,000 JPY
Net assets per share
443.62
443.32
410.86
412.11
406.57
407.02
306.31
307.64
257.92
257.01
Basic earnings (loss) per share
51.00
44.13
29.67
30.35
116.77
117.26
57.33
55.81
22.23
21.72
Diluted earnings per share
50.76
43.92
29.54
30.22
116.31
116.80
57.05
55.53
22.10
21.59
Equity-to-asset ratio
0.542 xbrli:pure
0.542 xbrli:pure
0.542 xbrli:pure
0.542 xbrli:pure
0.518 xbrli:pure
0.519 xbrli:pure
0.513 xbrli:pure
0.516 xbrli:pure
0.666 xbrli:pure
0.668 xbrli:pure
Rate of return on equity
0.119 xbrli:pure
0.103 xbrli:pure
0.073 xbrli:pure
0.074 xbrli:pure
0.327 xbrli:pure
0.329 xbrli:pure
0.203 xbrli:pure
0.198 xbrli:pure
0.089 xbrli:pure
0.086 xbrli:pure
Price-earnings ratio
16.8 xbrli:pure
19.5 xbrli:pure
47.6 xbrli:pure
46.6 xbrli:pure
19.3 xbrli:pure
19.2 xbrli:pure
62.5 xbrli:pure
64.2 xbrli:pure
105.9 xbrli:pure
108.4 xbrli:pure
Net cash provided by (used in) operating activities
9,312,000,000 JPY
-5,500,000,000 JPY
9,289,000,000 JPY
10,341,000,000 JPY
4,927,000,000 JPY
Net cash provided by (used in) investing activities
-2,690,000,000 JPY
-15,002,000,000 JPY
-3,250,000,000 JPY
-3,290,000,000 JPY
-4,161,000,000 JPY
Net cash provided by (used in) financing activities
-2,031,000,000 JPY
1,948,000,000 JPY
-2,179,000,000 JPY
8,304,000,000 JPY
2,048,000,000 JPY
Cash and cash equivalents
18,756,000,000 JPY
13,278,000,000 JPY
30,733,000,000 JPY
26,260,000,000 JPY
10,928,000,000 JPY
Number of employees
900 xbrli:pure
934 xbrli:pure
934 xbrli:pure
900 xbrli:pure
854 xbrli:pure
879 xbrli:pure
816 xbrli:pure
797 xbrli:pure
732 xbrli:pure
719 xbrli:pure
667 xbrli:pure
654 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.